RecruitingNCT06916195

Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation

CMV PED Study - A Retrospective Observational Study To Understand The Clinical And Economic Burden Associated With Cytomegalovirus Reactivation and Related Health Outcomes In Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation In Italy

Sponsor

MSD Italia S.r.l.

Enrollment

230 participants

Start Date

May 9, 2025

Study Type

OBSERVATIONAL

Conditions

cytomegalovirus infection Hematopoietic Stem Cells Transplantation

Summary

This observational retrospective analysis will provide useful information for clinicians and payers, and local guidelines committee members, to improve the understanding of Cytomegalovirus clinical and economic burden and clinical management of pediatric patients undergoing allogeneic Hematopoietic Stem Cells Transplantation in Italy.

Eligibility

Min Age: 0 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with hematopoietic stem cells transplantation and cytomegalovirus infection. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 0 Years to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(5)

IRCCS Istituto Giannina Gaslini, Trapianto di Cellule Staminali Emopoietiche, Dipartimento di Onco-Ematologia Pediatrica

Genova, Italy

Ospedale San Gerardo, Clinica Pediatrica

Monza, Italy

Azienda Ospedale-Università di Padova, Clinica di Oncoematologia Pediatrica

Padova, Italy

IRCCS Ospedale Pediatrico Bambino Gesù, Dipartimento di Pediatria Ematologia e Oncologia

Roma, Italy

Ospedale Infantile Regina Margherita, Dipartimento Patologia e Cura del Bambino

Torino, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06916195

Related Trials

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.

NCT056834573 locations